Maehara Y - Search Results

1

An Immunohistochemical Analysis of PD-L1 Protein Expression in Surgically Resected Small Cell Lung Cancer Using Different Antibodies and Criteria.

Takada K, Toyokawa G, Okamoto T, Akamine T, Takamori S, Katsura M, Fujishita T, Shoji F, Oda Y, Maehara Y. Takada K, et al. Among authors: maehara y. Anticancer Res. 2016 Jul;36(7):3409-12. Anticancer Res. 2016. PMID: 27354600

2

Inflammatory myofibroblastic tumor of the mediastinum presenting as superior vena cava syndrome.

Yamaguchi M, Yoshino I, Osoegawa A, Kameyama T, Tagawa T, Fukuyama S, Oda Y, Tsuneyoshi M, Maehara Y. Yamaguchi M, et al. Among authors: maehara y. J Thorac Cardiovasc Surg. 2003 Sep;126(3):870-2. doi: 10.1016/s0022-5223(03)00611-1. J Thorac Cardiovasc Surg. 2003. PMID: 14502173 Free article. Review. No abstract available.

3

Operative results of clinical stage I non-small cell lung cancer.

Yoshino I, Yamaguchi M, Tagawa T, Fukuyama S, Kameyama T, Osoegawa A, Maehara Y. Yoshino I, et al. Among authors: maehara y. Lung Cancer. 2003 Nov;42(2):221-5. doi: 10.1016/s0169-5002(03)00277-0. Lung Cancer. 2003. PMID: 14568690

4

Operative results of non-small cell lung cancer clinically presenting mediastinal lymph adenopathy.

Yoshino I, Yamaguchi M, Yohena T, Kameyama T, Kometani T, Osoegawa A, Maehara Y. Yoshino I, et al. Among authors: maehara y. Fukuoka Igaku Zasshi. 2003 Aug;94(8):250-8. Fukuoka Igaku Zasshi. 2003. PMID: 14579727 Free article.

5

Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.

Shikada Y, Yoshino I, Okamoto T, Fukuyama S, Kameyama T, Maehara Y. Shikada Y, et al. Among authors: maehara y. Clin Cancer Res. 2003 Nov 1;9(14):5282-6. Clin Cancer Res. 2003. PMID: 14614010

6

Multimodal treatment for resectable epithelial type malignant pleural mesothelioma.

Yoshino I, Yamaguchi M, Okamoto T, Ushijima C, Fukuyama Y, Ichinose Y, Maehara Y. Yoshino I, et al. Among authors: maehara y. World J Surg Oncol. 2004 May 5;2:11. doi: 10.1186/1477-7819-2-11. World J Surg Oncol. 2004. PMID: 15128453 Free PMC article.

7

The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer.

Ondo K, Sugio K, Yamazaki K, Yamaguchi M, Yano T, Yoshino I, Maehara Y. Ondo K, et al. Among authors: maehara y. Lung Cancer. 2004 Nov;46(2):205-13. doi: 10.1016/j.lungcan.2004.04.030. Lung Cancer. 2004. PMID: 15474669

8

Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.

Osoegawa A, Yoshino I, Tanaka S, Sugio K, Kameyama T, Yamaguchi M, Maehara Y. Osoegawa A, et al. Among authors: maehara y. J Clin Oncol. 2004 Oct 15;22(20):4165-73. doi: 10.1200/JCO.2004.01.035. J Clin Oncol. 2004. PMID: 15483027

9

The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft.

Suemitsu R, Yoshino I, Shoji F, Yamaguchi M, Tomita Y, Maehara Y. Suemitsu R, et al. Among authors: maehara y. J Surg Res. 2004 Nov;122(1):8-13. doi: 10.1016/j.jss.2004.04.019. J Surg Res. 2004. PMID: 15522308

10

Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer.

Suemitsu R, Yoshino I, Tomiyasu M, Fukuyama S, Okamoto T, Maehara Y. Suemitsu R, et al. Among authors: maehara y. Surg Today. 2004;34(11):896-901. doi: 10.1007/s00595-004-2853-y. Surg Today. 2004. PMID: 15526122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,993 results

Search Page

Filters